Advanced search
Publication Cover
Acta Cardiologica Volume 78, 2023 - Issue 5
Submit an article Journal homepage
116
Views
2
CrossRef citations to date
0
Altmetric
Original Scientific Papers

Relationship between lifestyle factors and hypertension: a cross-sectional analysis from the Gubbio study

Xavier Humberta Department of General Medicine, Medical School, UNICAEN, Normandie Université, Caen, FranceCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-2747-9229
ORCID Icon,
Idlir Licajb Department of Community Medicine, Faculty of Health Sciences, The UiT Arctic University of Norway, Tromsø, Norway
,
Sophie Fedrizzic Department of Pharmacology, UNICAEN, Normandie Université, Caen, France
,
Joachim Alexandrec Department of Pharmacology, UNICAEN, Normandie Université, Caen, France
,
Alessandro Menottid Association for Cardiac Research, Rome, Italy
,
Alain Manriquee Department of Nuclear Medicine, CHU Caen, EA 4650UNICAEN, Normandie Université, Caen, France
,
Stéphane Allouchef Department of Biochemistry, CHU Caen, EA 4650, UNICAEN, Normandie Université, Caen, France
,
Emmanuel Touzég Department of Neurology, CHU Caen, INSERM U 1237. UNICAEN, Normandie Université, Caen, France
,
Oscar Terradura-Vagnarellih Centro Studi Epidemiologici di Gubbio (CeSEG), Gubbio, Italy
&
Paolo E. Puddui EA 4650, UNICAEN, Normandie Université, Caen, France
 show all
Pages 565-573 | Received 29 Nov 2021, Accepted 05 Jun 2022, Published online: 21 Jun 2022

References

  • MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet Lond Engl. 1990;335(8692):765–774.
  • Ettehad D, Emdin CA, Kiran A, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet Lond Engl. 2016;387(10022):957–967.
  • Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: the task force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36(10):1953–2041.
  • Chow CK, Teo KK, Rangarajan S, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013;310(9):959–968.
  • NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants. Lancet Lond Engl. 2017;389:37–55.
  • Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31(7):1281–1357.
  • Appel LJ, Champagne CM, Harsha DW, et al. Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. JAMA. 2003;289:2083–2093.
  • Laurenzi M, Cirillo M, Terradura Vagnarelli O, et al. A report on the Gubbio Study thirty-eight years after its inception. Panminerva Med. 2021;63(4):410–415.
  • Kawasaki T, Itoh K, Uezono K, et al. A simple method for estimating 24 h urinary sodium and potassium excretion from second morning voiding urine specimen in adults. Clin Exp Pharmacol Physiol. 1993;20(1):7–14.
  • Lanti M, Puddu PE, Vagnarelli OT, et al. Antihypertensive treatment is not a risk factor for major cardiovascular events in the Gubbio residential cohort study. J Hypertens. 2015;33(4):736–744; discussion 744.
  • Lelong H, Galan P, Kesse-Guyot E, et al. Relationship between nutrition and blood pressure: a cross-sectional analysis from the NutriNet-Santé study, a French web-based cohort study. Am J Hypertens. 2015;28(3):362–371.
  • Cherfan M, Vallée A, Kab S, et al. Unhealthy behavior and risk of hypertension: the CONSTANCES population-based cohort. J Hypertens. 2019;37(11):2180–2189.
  • Mente A, O'Donnell M, Rangarajan S, et al. Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies. Lancet Lond Engl. 2016;388(10043):465–475.
  • Jordan J, Engeli S, Redon J, et al. European society of hypertension working group on obesity: background, aims and perspectives. J Hypertens. 2007;25(4):897–900.
  • Czernichow S, Castetbon K, Salanave B, et al. Determinants of blood pressure treatment and control in obese people: evidence from the general population. J Hypertens. 2012;30(12):2338–2344.
  • Must A, Spadano J, Coakley EH, et al. The disease burden associated with overweight and obesity. JAMA. 1999;282(16):1523–1529.
  • Neter JE, Stam BE, Kok FJ, et al. Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension. 2003;42(5):878–884.
  • Cherfan M, Blacher J, Asmar R, et al. Prevalence and risk factors of hypertension: a nationwide cross-sectional study in Lebanon. J Clin Hypertens. 2018;20(5):867–879.
  • Piepoli MF, Hoes AW, Agewall S, et al. 2016) 2016 European guidelines on cardiovascular disease prevention in clinical practice: the sixth joint task force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of 10 societies and by invited experts)developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016;37(29):2315–2381.
  • Holmes MV, Dale CE, Zuccolo L, et al. Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data. BMJ. 2014;349:g4164.
  • Elliott P, Stamler J, Nichols R, et al. Intersalt revisited: further analyses of 24 hour sodium excretion and blood pressure within and across populations. Intersalt Cooperative Research Group. BMJ. 1996;312(7041):1249–1253.
  • Ding M, Bhupathiraju SN, Satija A, et al. Long-term coffee consumption and risk of cardiovascular disease: a systematic review and a dose-response meta-analysis of prospective cohort studies. Circulation. 2014;129(6):643–659.
  • Li G, Zhang Y, Thabane L, et al. Effect of green tea supplementation on blood pressure among overweight and obese adults: a systematic review and meta-analysis. J Hypertens. 2015;33(2):243–254.
  • Seltzer CC. Effect of smoking on blood pressure. Am Heart J. 1974;87(5):558–564.
  • Cannoletta M, Cagnacci A. Modification of blood pressure in postmenopausal women: role of hormone replacement therapy. Int J Womens Health. 2014;6:745–757.
  • Jeong J, Zhu H, Harris RA, et al. Ethnic differences in nighttime melatonin and nighttime blood pressure: a study in European Americans and African Americans. Am J Hypertens. 2019;32(10):968–974.
  • Rimpelä JM, Niiranen T, Jula A, et al. Genome-wide association study of white-coat effect in hypertensive patients. Blood Press. 2019;28(4):239–249.
  • Saito I, Takeshita E, Murata K, et al. Serum cortisol in the white-coat phenomenon. Blood Press Monit. 1996;1(4):381–383.
  • SCORE2 Working Group and ESC Cardiovascular Risk Collaboration. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J. 2021;42:2439–2454.
  • SCORE2-OP Working Group and ESC Cardiovascular Risk Collaboration. SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions. Eur Heart J. 2021;42:2455–2467.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Committed to improving the lives of patients with Type 2 Diabetes, Heart Failure and Chronic Kidney Disease.
Novartis. Your partner in Heart Failure & Atherosclerosis >>

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.